◀ Back to EPHB2
EPHB2 — SFTPC
Text-mined interactions from Literome
Bektas et al., Biochemistry 2003
:
In addition, neither
SPC nor LPC stimulated the binding of GTPgammaS to membranes prepared from GPR4 expressing cells and did not
activate ERK1/2 ... Collectively, our results suggest that
SPC and LPC are not the ligands for GPR4 and that this receptor may constitutively
inhibit ERK1/2 activation
Mathieson et al., Br J Pharmacol 2006
:
In contrast,
SPC increased p38MAPK phosphorylation ( 3.0+/-0.3-fold increase ) but did not
stimulate ERK1/2 ... CREB activation by
SPC required both p38MAPK and CaMK activation, but not
ERK1/2
Kim et al., Pigment Cell Res 2006
(MAP Kinase Signaling System) :
These results suggest that the ERK pathway is involved in the melanogenic signaling cascade, and that
ERK activation by
SPC reduces melanin synthesis via MITF downregulation
Jeon et al., J Cell Biochem 2007
:
SPC treatment
induced sustained activation of an extracellular signal regulated kinase (
ERK ), in contrast to transient activation of ERK in response to platelet derived growth factor (PDGF)-BB, which stimulated proliferation of MS1 cells ... Both the
SPC induced cell death and
ERK activation were abolished by pretreatment of the cells with the MEK inhibitor U0126 or by overexpression of a dominant negative mutant of MEK1 ( DN-MEK1 ) ... Pretreatment of the cells with N-acetylcysteine, an antioxidant, completely prevented the
SPC induced ROS generation, apoptosis, and
ERK activation, whereas the ROS generation was not abrogated by treatment with U0126 ... Consistent with these results,
SPC induced cell death of human umbilical vein endothelial cells ( HUVECs ) through ROS mediated activation of
ERK
Kwon et al., J Dermatol Sci 2007
(MAP Kinase Signaling System) :
Protein kinase C ( PKC ) activation by phorbol myristate acetate ( PMA ) potentiated IL-6 mRNA expression, whereas PKC inhibition by bisindolylmaleimide blocked
SPC induced p42/44
ERK phosphorylation and IL-6 expression
Moon et al., Int J Biochem Cell Biol 2007
:
Pretreatment of the cells with U0126, an MEK inhibitor, markedly attenuated the SPC induced expression of FN and delayed phosphorylation of Smad2, suggesting that
ERK is
involved in the
SPC induction of FN expression through activation of Smad2
Jeong et al., Mol Cell Biochem 2012
(Hypopigmentation...) :
In the present study, we confirmed that
SPC activated
ERK and that a specific inhibitor of the ERK pathway ( PD98059 ) recovered SPC induced hypopigmentation